Clinical Trial Update: Efficacy and Safety Study of Shenwu Capsule [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Shenwu Capsule for mild cognitive impairment has completed, with results posted in October 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Shenwu Capsule

Snippet

Sponsor: North China Pharmaceutical Group Corporation | Conditions: Mild Cognitive Impairment | Phase 3 | Status: COMPLETED | Results posted: 2014-10-10